Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3709464010 | Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3709465011 | Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3709466012 | Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4680491000052117 | läkemedel som innehåller dehydrocholsyra, pankreatin och simetikon, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Is a | Product containing dehydrocholic acid and pancreatin and simeticone (medicinal product) | true | Inferred relationship | Some | ||
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Has active ingredient | Simeticone | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Is a | Simeticone-containing product in oral dose form | true | Inferred relationship | Some | ||
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Has active ingredient | Pancreatin (substance) | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Has active ingredient | Dehydrocholic acid (substance) | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Is a | Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Plays role | Digestant therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | False | Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Inferred relationship | Some | |
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Is a | True | Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets